Comparison of Intravenous Palivizumab and Standard of Care for Treatment of Respiratory Syncytial Virus Infection in Mechanically Ventilated Pediatric Patients

Journal of Pediatric Pharmacology and Therapeutics - United States
doi 10.5863/1551-6776-21.2.146
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pediatric Pharmacy Advocacy Group

Related search

Respiratory Syncytial Virus (RSV) Immune Globulin and Palivizumab for Prevention of RSV Infection

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2000English

4cps-069 Evaluation of Palivizumab as Prophylaxis Against Respiratory Syncytial Virus Infection

2020English

Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis

Archives of Disease in Childhood: Fetal and Neonatal Edition
PediatricsGynecologyPerinatologyObstetricsMedicineChild Health
2005English

Intravenous Immunoglobulin Treatment of Respiratory Syncytial Virus Infections in Infants and Young Children.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Diagnosis of Respiratory Syncytial Virus Infection

Open Microbiology Journal
ImmunologyMicrobiology
2011English

Respiratory Syncytial Virus Immune Globulin Treatment of Lower Respiratory Tract Infection in Pediatric Patients Undergoing Bone Marrow Transplantation – A Compassionate Use Experience

Bone Marrow Transplantation
TransplantationHematology
2000English

Comparison of Clinical Features of Pediatric Respiratory Syncytial Virus and Human Metapneumovirus Infections

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2009English

Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants

PharmacoEconomics - Open
Health PolicyPharmacology
2017English

Severe Respiratory Syncytial Virus Infection

Indian Journal of Pediatrics
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy